These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 29243128)
61. Indoor radon survey in Greenland and dose assessment. Hansen V; Petersen D; Søgaard-Hansen J; Rigét FF; Mosbech A; Clausen DS; Mulvad G; Rönnqvist T J Environ Radioact; 2023 Feb; 257():107080. PubMed ID: 36446183 [TBL] [Abstract][Full Text] [Related]
62. [Incorporation Monitoring of Staff using I-131 and Lu-177 in a Nuclear Medicine Ward]. Wanke C; Szemerski B; Geworski L Nuklearmedizin; 2022 Aug; 61(4):333-338. PubMed ID: 35388445 [TBL] [Abstract][Full Text] [Related]
63. Trends in Occupational Radiation Doses for U.S. Radiologic Technologists Performing General Radiologic and Nuclear Medicine Procedures, 1980-2015. Villoing D; Borrego D; Preston DL; Alexander BH; Rose A; Salasky M; Linet MS; Lee C; Kitahara CM Radiology; 2021 Sep; 300(3):605-612. PubMed ID: 34156301 [TBL] [Abstract][Full Text] [Related]
64. A methodology for auto-monitoring of internal contamination by 131I in nuclear medicine workers. Vidal MV; Dantas AL; Dantas BM Radiat Prot Dosimetry; 2007; 125(1-4):483-7. PubMed ID: 17766259 [TBL] [Abstract][Full Text] [Related]
65. Fifteen years of radiological protection experience in a regional radiopharmacy. Hilditch TE; Elliott AT; Anstee DE; Murray T Health Phys; 1990 Jul; 59(1):109-16. PubMed ID: 2358349 [TBL] [Abstract][Full Text] [Related]
66. Radiation dose rates from patients receiving iodine-131 therapy for carcinoma of the thyroid. Barrington SF; Kettle AG; O'Doherty MJ; Wells CP; Somer EJ; Coakley AJ Eur J Nucl Med; 1996 Feb; 23(2):123-30. PubMed ID: 8925845 [TBL] [Abstract][Full Text] [Related]
67. Exposure of critical groups to nuclear medicine patients. Mountford PJ; O'Doherty MJ Appl Radiat Isot; 1999 Jan; 50(1):89-111. PubMed ID: 10028630 [TBL] [Abstract][Full Text] [Related]
68. Evaluation of internal exposure of nuclear medicine staff through in vivo and in vitro bioassay techniques. Lucena EA; Rebelo AM; Araújo F; Sousa WO; Dantas AL; Dantas BM; Corbo R Radiat Prot Dosimetry; 2007; 127(1-4):465-8. PubMed ID: 17681960 [TBL] [Abstract][Full Text] [Related]
69. Safety management of nuclear medicine personnel with visualisation of air dose rate. Kawase S; Ohno K; Nakamoto Y; Miyatake H Radiat Prot Dosimetry; 2015 Jul; 165(1-4):439-42. PubMed ID: 25889608 [TBL] [Abstract][Full Text] [Related]
70. [Radioactivity levels of the air inhaled by personnel of a radioiodine therapy unit]. Krześniak JW; Fill H; Oberladstätter M Nuklearmedizin; 1987 Jun; 26(3):143-6. PubMed ID: 3628023 [TBL] [Abstract][Full Text] [Related]
71. Combination of liquid scintillation counting and passive sampling strategy for the determination of ¹³¹I in air and application to estimate the inhalation dose to the staff of a nuclear medicine service. Jiménez F; Deban L; Pardo R; García-Talavera P J Environ Sci Health A Tox Hazard Subst Environ Eng; 2012; 47(12):1843-8. PubMed ID: 22755532 [TBL] [Abstract][Full Text] [Related]
72. EFFECTIVE DOSES DUE TO OUTDOOR AND INDOOR RADON AT A MEDITERRANEAN SITE. Kikaj D; Vaupotič J Radiat Prot Dosimetry; 2019 Dec; 187(2):215-219. PubMed ID: 31165887 [TBL] [Abstract][Full Text] [Related]
73. Personal dose equivalent Hp(0.07) of medical personnel occupationally exposed to ionizing radiation during 2001-2011. Papierz S; Kacprzyk J; Kamiński Z; Adamowicz M; Zmyślony M Med Pr; 2012; 63(6):623-7. PubMed ID: 23394003 [TBL] [Abstract][Full Text] [Related]
74. Follow-up on thyroidal uptake after radioiodine therapy: how robust is the peri-therapeutic dosimetry? Eschner W; Kobe C; Schicha H Z Med Phys; 2011 Dec; 21(4):258-65. PubMed ID: 21719262 [TBL] [Abstract][Full Text] [Related]
75. NTP Toxicity Study Report on the atmospheric characterization, particle size, chemical composition, and workplace exposure assessment of cellulose insulation (CELLULOSEINS). Morgan DL Toxic Rep Ser; 2006 Aug; (74):1-62, A1-C2. PubMed ID: 17160106 [TBL] [Abstract][Full Text] [Related]
76. A multi-institutional assessment of eye lens dose in nuclear medicine clinics. Abuqbeitah M; Demir M; Işikci NI; Kozanlilar B; Kovan B; Yeyin N; Fikret Çermik T; Şanli Y; Sönmezoğlu K Nucl Med Commun; 2023 Sep; 44(9):772-776. PubMed ID: 37464817 [TBL] [Abstract][Full Text] [Related]
77. Measurements of finger doses in x-ray guided surgery, nuclear medicine and research. Saether HK; Davidson TM; Widmark A; Wøhni T Radiat Prot Dosimetry; 2005; 113(4):392-5. PubMed ID: 15817576 [TBL] [Abstract][Full Text] [Related]
78. A Study of Thyroid 131I Activity of Five Human Subjects Exposed to a Radioactive Plume at Tamura City in Fukushima. Uchiyama K; Miyashita M; Sato H; Tanishima Y; Maeda S; Yoshikawa J; Kimura S Health Phys; 2015 Dec; 109(6):573-81. PubMed ID: 26509625 [TBL] [Abstract][Full Text] [Related]
79. INTERNAL DOSES OF THREE PERSONS STAYING 110 KM SOUTH OF THE FUKUSHIMA DAIICHI NUCLEAR POWER STATION DURING THE ARRIVAL OF RADIOACTIVE PLUMES BASED ON DIRECT MEASUREMENTS. Kurihara O; Nakagawa T; Takada C; Tani K; Kim E; Momose T Radiat Prot Dosimetry; 2016 Sep; 170(1-4):420-4. PubMed ID: 26868009 [TBL] [Abstract][Full Text] [Related]
80. Aerosol residence times and changes in radioiodine-131I and radiocaesium-137 Cs activity over Central Poland after the Fukushima-Daiichi Nuclear reactor accident. Długosz-Lisiecka M; Bem H J Environ Monit; 2012 May; 14(5):1483-9. PubMed ID: 22481111 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]